These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 27010830)

  • 1. Twin Peaks: A/H1N1 Pandemic Influenza Virus Infection and Vaccination in Norway, 2009-2010.
    Van Effelterre T; Dos Santos G; Shinde V
    PLoS One; 2016; 11(3):e0151575. PubMed ID: 27010830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influenza in Poland in 2011-2012 and in 2011/2012 and 2012/2013 epidemic seasons.
    Czarkowski MP; Hallmann-Szelińska E; Staszewska E; Bednarska K; Kondratiuk K; Brydak LB
    Przegl Epidemiol; 2014; 68(3):455-63, 559-65. PubMed ID: 25391010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pandemic influenza A(H1N1)pdm09 improves vaccination routine in subsequent years: a cohort study from 2009 to 2011.
    Tacken MA; Jansen B; Mulder J; Visscher S; Heijnen ML; Campbell SM; Braspenning JC
    Vaccine; 2013 Jan; 31(6):900-5. PubMed ID: 23246546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness of pandemic and seasonal influenza vaccine in preventing pandemic influenza A(H1N1)2009 infection in England and Scotland 2009-2010.
    Hardelid P; Fleming DM; McMenamin J; Andrews N; Robertson C; SebastianPillai P; Ellis J; Carman W; Wreghitt T; Watson JM; Pebody RG
    Euro Surveill; 2011 Jan; 16(2):. PubMed ID: 21251487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pandemic influenza A (H1N1)v vaccination status and factors affecting vaccination: Ankara and Diyarbakır 2009 data from Turkey].
    Ertek M; Sevencan F; Kalaycıoğlu H; Gözalan A; Simşek C; Culha G; Dorman V; Ozlü A; Arıkan F; Aktaş D; Akın L; Korukluoğlu G; Sevindi DF
    Mikrobiyol Bul; 2011 Oct; 45(4):684-96. PubMed ID: 22090299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pandemic vaccination strategies and influenza severe outcomes during the influenza A(H1N1)pdm09 pandemic and the post-pandemic influenza season: the Nordic experience.
    Gil Cuesta J; Aavitsland P; Englund H; Gudlaugsson Ó; Hauge SH; Lyytikäinen O; Sigmundsdóttir G; Tegnell A; Virtanen M; ; Krause TG
    Euro Surveill; 2016 Apr; 21(16):. PubMed ID: 27123691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of vaccine against pandemic influenza A/H1N1 among people with underlying chronic diseases: cohort study, Denmark, 2009-10.
    Emborg HD; Krause TG; Hviid A; Simonsen J; Mølbak K
    BMJ; 2011 Jan; 344():d7901. PubMed ID: 22277542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epilepsy in Children After Pandemic Influenza Vaccination.
    Håberg SE; Aaberg KM; Surén P; Trogstad L; Ghaderi S; Stoltenberg C; Magnus P; Bakken IJ
    Pediatrics; 2018 Mar; 141(3):. PubMed ID: 29449342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of vaccines and antivirals during the major 2009 A(H1N1) pandemic wave in Norway--and the influence of vaccination timing.
    Blasio BF; Iversen BG; Tomba GS
    PLoS One; 2012; 7(1):e30018. PubMed ID: 22253862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccines against influenza A (H1N1) pandemic.
    Valdespino-Gomez JL; Garcia-Garcia L; de León-Rosales SP
    Arch Med Res; 2009 Nov; 40(8):693-704. PubMed ID: 20304259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influenza pandemic (H1N1) 2009 activity during summer 2009. Effectiveness of the 2008-9 trivalent vaccine against pandemic influenza in Spain.
    Larrauri A; Savulescu C; Jiménez-Jorge S; Pérez-Breña P; Pozo F; Casas I; Ledesma J; de Mateo S;
    Gac Sanit; 2011; 25(1):23-8. PubMed ID: 21334788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High prevalence of antibodies to the 2009 pandemic influenza A(H1N1) virus in the Norwegian population following a major epidemic and a large vaccination campaign in autumn 2009.
    Waalen K; Kilander A; Dudman SG; Krogh GH; Aune T; Hungnes O
    Euro Surveill; 2010 Aug; 15(31):. PubMed ID: 20738992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Repeated seasonal influenza vaccination among elderly in Europe: Effects on laboratory confirmed hospitalised influenza.
    Rondy M; Launay O; Castilla J; Costanzo S; Puig-Barberà J; Gefenaite G; Larrauri A; Rizzo C; Pitigoi D; Syrjänen RK; Machado A; Kurečić Filipović S; Krisztina Horváth J; Paradowska-Stankiewicz I; Marbus S; ; Moren A
    Vaccine; 2017 Aug; 35(34):4298-4306. PubMed ID: 28709555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. No effect of 2008/09 seasonal influenza vaccination on the risk of pandemic H1N1 2009 influenza infection in England.
    Pebody R; Andrews N; Waight P; Malkani R; McCartney C; Ellis J; Miller E
    Vaccine; 2011 Mar; 29(14):2613-8. PubMed ID: 21292008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Narcolepsy and hypersomnia in Norwegian children and young adults following the influenza A(H1N1) 2009 pandemic.
    Trogstad L; Bakken IJ; Gunnes N; Ghaderi S; Stoltenberg C; Magnus P; Håberg SE
    Vaccine; 2017 Apr; 35(15):1879-1885. PubMed ID: 28302408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influenza and risk of later celiac disease: a cohort study of 2.6 million people.
    Kårhus LL; Gunnes N; Størdal K; Bakken IJ; Tapia G; Stene LC; Håberg SE; Mårild K
    Scand J Gastroenterol; 2018 Jan; 53(1):15-23. PubMed ID: 29076383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Events supposedly attributable to vaccination or immunization during pandemic influenza A (H1N1) vaccination campaigns in Latin America and the Caribbean.
    Ropero-Álvarez AM; Whittembury A; Bravo-Alcántara P; Kurtis HJ; Danovaro-Holliday MC; Velandia-González M
    Vaccine; 2015 Jan; 33(1):187-92. PubMed ID: 25444798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Transmissibility and severity of the pandemic influenza A (H1N1) 2009 virus in Spain].
    Simón Méndez L; de Mateo Ontañón S; Larrauri Cámara A; Jiménez-Jorge S; Vaqué Rafart J; Pérez Hoyos S;
    Gac Sanit; 2011; 25(4):296-302. PubMed ID: 21543138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of baseline age-specific antibody prevalence and incidence of infection to novel influenza A/H1N1 2009.
    Hardelid P; Andrews NJ; Hoschler K; Stanford E; Baguelin M; Waight PA; Zambon M; Miller E
    Health Technol Assess; 2010 Dec; 14(55):115-92. PubMed ID: 21208549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of the pandemic H1N1 influenza vaccines against laboratory-confirmed H1N1 infections: population-based case-control study.
    Mahmud S; Hammond G; Elliott L; Hilderman T; Kurbis C; Caetano P; Van Caeseele P; Kettner J; Dawood M
    Vaccine; 2011 Oct; 29(45):7975-81. PubMed ID: 21884747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.